The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.

Also called NCT06433011

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Thrombolex, Inc. (from the registry)
Registry
  • NCT NCT06433011
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06433011. Allocation not applicable; no masking; primary purpose treatment. Start 2024-10-17 (actual); primary completion 2028-04-25 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism
Intervention (Device)
The Bashir™ Endovascular Catheter
Intervention (Drug)
r-tPA
Lead sponsor
Thrombolex, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06433011
Content hash
48b6a1e5b28edeae508b96ffa4a3af3258d988b079e97cc8bad2a828423c0a10